Skip to main content
Log in

The new ACC/AHA guidelines on the treatment of dyslipidemia: cons

  • IM - DEBATE
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Stone NJ, Robinson JG, Lichtenstein AH et al (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 129:S1–S45

    Article  PubMed  Google Scholar 

  2. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr et al (2004) Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 110:227–239

    Article  PubMed  Google Scholar 

  3. Reiner Z, Catapano AL, De Backer G et al (2011) ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769–1818

    Article  PubMed  Google Scholar 

  4. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB (2009) Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 15(9):728–740

    PubMed  Google Scholar 

  5. Lars Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487–497

    Article  PubMed  Google Scholar 

  6. Nieuwkerk PT, Nierman MC, Vissers MN, Locadia M et al (2012) Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk. Am J Cardiol 110:666–672

    Article  PubMed  Google Scholar 

  7. Haynes RB, McDonald H, Garg AX, Montague P (2002) Interventions for helping patients to follow prescriptions for medications. Cochrane Database of Syst Rev. (2):CD000011. doi:10.1002/14651858.CD000011

  8. Degli Esposti L, Saragoni S, Batacchi P, Benemei S et al (2012) Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Clin Ther 34:190–199

    Article  PubMed  Google Scholar 

  9. Ridker PM, Cook NR (2013) Statins: new American guidelines for prevention of cardiovascular disease. Lancet 382:1762–1765

    Article  PubMed  Google Scholar 

  10. Kavousi M, Leening MJG, Nanchen D, Greenland P et al (2014) Comparison of application of the ACC/AHA guidelines, adult treatment panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA 311(14):1416–1423

    Article  CAS  PubMed  Google Scholar 

  11. Kausik KR, Kastelein JJP, Boekholdt SM, Nicholls SJ et al (2014) The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J 35:960–968

    Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alberto Zambon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zambon, A. The new ACC/AHA guidelines on the treatment of dyslipidemia: cons. Intern Emerg Med 10, 119–122 (2015). https://doi.org/10.1007/s11739-014-1165-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-014-1165-5

Keywords

Navigation